Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: A single-center experience

Circulation: Cardiovascular Interventions

Volumn 6, Issue 3, 2013, Pages 301-310

  Buber, Jonathan ^a   Bergersen, Lisa ^a   Lock, James E ^a   Gauvreau, Kimberlee ^a   Esch, Jesse J ^a   Landzberg, Michael J ^a   Valente, Anne Marie ^a   Sandora, Thomas J ^a   Marshall, Audrey C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Congenital cardiac defect; Infection; Percutaneous valve implantation

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BLOODSTREAM INFECTION; CARDIAC PATIENT; CHILD; COMPARATIVE STUDY; COMPASSIONATE USE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOCARDITIS; FALLOT TETRALOGY; FEMALE; FEVER; FOLLOW UP; HAEMOPHILUS; HEART RIGHT VENTRICLE OUTFLOW TRACT; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALAISE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA; PULMONARY VALVE PROSTHESIS; RISK FACTOR; SCHOOL CHILD; SEX; SEX RATIO;

CONGENITAL CARDIAC DEFECT; INFECTION; PERCUTANEOUS VALVE IMPLANTATION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BIOPROSTHESIS; BOSTON; CHILD, PRESCHOOL; ENDOCARDITIS, BACTERIAL; FEMALE; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; PULMONARY VALVE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884472470     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.112.000348     Document Type: Article

References (28)

1. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineering of heart valves: valve replacement study in a lamb model. Ann Thorac Surg. 1995;60:S513-S516.
2. Romeih S, Kroft LJ, Bokenkamp R, Schalij MJ, Grotenhuis H, Hazekamp MG, Groenink M, de Roos A, Blom NA. Delayed improvement of right ventricular diastolic function and regression of right ventricular mass after percutaneous pulmonary valve implantation in patients with congenital heart disease. Am Heart J. 2009;158:40-46.
3. McElhinney DB, Hellenbrand WE, Zahn EM, Jones TK, Cheatham JP, Lock JE, Vincent JA. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122:507-516.
4. Coats L, Khambadkone S, Derrick G, Sridharan S, Schievano S, Mist B, Jones R, Deanfield JE, Pellerin D, Bonhoeffer P, Taylor AM. Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation. 2006;113: 2037-2044.
5. Lurz P, Nordmeyer J, Giardini A, Khambadkone S, Muthurangu V, Schievano S, Thambo JB, Walker F, Cullen S, Derrick G, Taylor AM, Bonhoeffer P. Early versus late functional outcome after successful percutaneous pulmonary valve implantation: are the acute effects of altered right ventricular loading all we can expect? J Am Coll Cardiol. 2011;57: 724-731.
6. Mahesh B, Angelini G, Caputo M, Jin XY, Bryan A. Prosthetic valve endocarditis. Ann Thorac Surg. 2005;80:1151-1158.
7. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy Thorac Cardiovasc Surg. 1986; 92:776-83.
8. Habib G, Tribouilloy C, Thuny F, Giorgi R, Brahim A, Amazouz M, Remadi JP, Nadji G, Casalta JP, Coviaux F, Avierinos JF, Lescure X, Riberi A, Weiller PJ, Metras D, Raoult D. Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart. 2005;91:954-959.
9. Kloster FE. Complications of artificial heart valves. JAMA. 1979;241: 2201-2203.
10. Bashore TM, Cabell C, Fowler V Jr. Update on infective endocarditis. Curr Probl Cardiol. 2006;31:274-352.
11. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318-1330.
12. Kuyvenhoven JP, van Rijk-Zwikker GL, Hermans J, Thompson J, Huysmans HA. Prosthetic valve endocarditis: analysis of risk factors for mortality. Eur J Cardiothorac Surg. 1994;8:420-424.
13. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis- Prospective Cohort Study. Arch Intern Med. 2009;169:463-473.
14. Chen XJ, Smith PB, Jaggers J, Lodge AJ. Bioprosthetic pulmonary valve replacement: Contemporary analysis of a large, single-center series of 170 cases. J Thorac Cardiovasc Surg. November 1, 2012. doi: 10.1016/j. jtcvs.2012.09.081. Accessed May 15, 2013.
15. Caldarone CA, McCrindle BW, Van Arsdell GS, Coles JG, Webb G, Freedom RM, Williams WG. Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J Thorac Cardiovasc Surg. 2000;120:1022-1030; discussion 1031.
16. Patel M, Iserin L, Bonnet D, Boudjemline Y. Atypical malignant late infective endocarditis of Melody valve. J Thorac Cardiovasc Surg. 2012;143:e32-e35.
17. Atamanyuk I, Raja SG, Kostolny M. Bartonella henselae endocarditis of percutaneously implanted pulmonary valve: a case report. J Heart Valve Dis. 2011;20:94-97.
18. Bhat DP, Forbes TJ, Aggarwal S. A Case of Life-threatening Staphylococcus aureus Endocarditis Involving Percutaneous Transcatheter Prosthetic Pulmonary Valve. Congenit Heart Dis. October 24, 2012. doi: 10.1111/chd.12013. Accessed May 15, 2013.
19. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the U.S. Clinical trial. J Am Coll Cardiol. 2009;54:1722-1729.
20. Chambers CE, Eisenhauer MD, McNicol LB, Block PC, Phillips WJ, Dehmer GJ, Heupler FA, Blankenship JC; Members of the Catheterization Lab Performance Standards Committee for the Society for Cardiovascular Angiography and Interventions. Infection control guidelines for the cardiac catheterization laboratory: society guidelines revisited. Catheter Cardiovasc Interv. 2006;67:78-86.
21. Peng LF, McElhinney DB, Nugent AW, Powell AJ, Marshall AC, Bacha EA, Lock JE. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience. Circulation. 2006;113:2598-2605.
22. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638.
23. Day MD, Gauvreau K, Shulman S, Newburger JW. Characteristics of children hospitalized with infective endocarditis. Circulation. 2009;119:865-870.
24. Alonso-Valle H, Fariñas-Alvarez C, García-Palomo JD, Bernal JM, Martín-Durán R, Gutiérrez Díez JF, Revuelta JM, Fariñas MC. Clinical course and predictors of death in prosthetic valve endocarditis over a 20- year period. J Thorac Cardiovasc Surg. 2010;139:887-893.
25. Johnson JA, Boyce TG, Cetta F, Steckelberg JM, Johnson JN. Infective endocarditis in the pediatric patient: a 60-year single-institution review. Mayo Clin Proc. 2012;87:629-635.
26. McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987;82:681-688.
27. Mandell GL. Principles and practice of infectious disease. 5th ed. New York: Churchill Livingstone; 2000.
28. Muñoz P, Blanco JR, Rodríguez-Creixéms M, García E, Delcan JL, Bouza E. Bloodstream infections after invasive nonsurgical cardiologic procedures. Arch Intern Med. 2001;161:2110-2115.